Back

Clinical outcomes and prognostic implications of residual congestion at discharge in acute heart failure

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Acute heart failure - clinical 1 Clinical HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Mirta Diez

Instituto Cardiovascular De Buenos Aires, Buenos Aires (Argentina)

7 More presentations in this session

Presentation thumbnail
Sex and gender differences in characteristics, treatment, and short-term prognosis among patients with acute myocarditis in Korea
Doctor M. Kim (Seoul, KR)
Abstract Slides
Presentation thumbnail
Impact of cardiac sarcoidosis on admissions for acute-on-chronic combined systolic and diastolic heart failure
Mr G. Yeap (GB)
Abstract Slides Video
Presentation thumbnail
The early evaluation of diuretic resistance as recommended by ESC Guidelines predicts long-term outcomes in patients with acute heart failure.
Mr J. Lopez Azor (Majadahonda, ES)
Abstract Slides Video
Presentation thumbnail
A multi-centre audit on the impact of optimal guideline directed medical therapy (GDMT) on left ventricular ejection fraction (LVEF) in Irish heart failure nurse-led clinics.
Ms J. Aherne (Cork, IE)
Abstract Slides Video
Presentation thumbnail
Congestion as a crucial factor determining albuminuria in in patients with cardiorenal disease
Doctor P. Llacer (Madrid, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Acute heart failure - clinical 1

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Residual congestion assessment: in search of the Holy Grail
thumbnail
Congress Presentation
Subclinical congestion at discharge at patients admitted with acute decompensation of heart failure
thumbnail
Congress Presentation
Residual subclinical congestion evaluated through non-invasive techniques in hospitalized patients with acute heart failure and association with outcomes: an analysis from a prospective single-centre

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources